Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ametros is a leading healthcare technology and services company specializing in the professional administration of medical settlement funds, particularly Medicare Set-Asides (MSAs). The company's core offering is the CareGuard platform, which assists injured individuals in managing their post-settlement medical care and expenses while ensuring compliance with Medicare reporting requirements. By leveraging a proprietary technology suite, Ametros provides users with access to discounted medical provider networks and pharmacy benefits, effectively extending the life of their settlement funds. In early 2024, Ametros was acquired by Aon, a global professional services firm, to enhance its specialized settlement solutions within the casualty claims and insurance sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ametros.